News

Thank you for your interest in Tactile Medical. Read about our latest news, events, accreditations, and recognitions.

Tactile Medical to Release First Quarter 2017 Financial Results on May 8, 2017

April 10, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today announced that first quarter 2017 financial results will be released after the market closes on Monday, May 8. Read the full press release here.


Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results; Provides 2017 Outlook

February 27, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today reported financial results for the fourth quarter and year ended December 31, 2016. Read the full press release here.


Tactile Medical to Release Fourth Quarter and Fiscal Year 2016 Financial Results on February 27th

February 14, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today announced that fourth quarter and fiscal year 2016 financial results will be released after the market closes on February 27th. Read the full press release here.


Tactile Medical to Ring the Nasdaq Stock Market Opening Bell

January 17, 2017

Tactile Systems Technology Inc. (“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices that treat lymphedema and venous ulcers, will celebrate its 2016 initial public offering (“IPO”) by ringing the Nasdaq Stock Market opening bell in New York City on Tuesday, January 17. The Company began trading on the Nasdaq Global Market on July 28, 2016. Read the full press release here.


Tactile Systems Technology, Inc. Reports Preliminary Full Year and Fourth Quarter 2016 Revenue Results

January 9, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today reported preliminary revenue results for the full year and fourth quarter ended December 31, 2016. Read the full press release here.


Tactile Systems Technology, Inc. Reports Third Quarter 2016 Financial Results and Updates Fiscal Year 2016 Outlook

November 10, 2016

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today reported financial results for the third quarter and nine months ended September 30, 2016. Read the full press release here.


Tactile Medical Receives FDA 510(k) Clearance for New Indication of At-Home Lymphedema Treatment

September 22, 2016

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Flexitouch System in treating lymphedema of the head and neck, a common consequence of head and neck cancer. Read the full press release here.


Tactile Systems Technology, Inc. Reports Second Quarter 2016 Financial Results and Introduces Fiscal Year 2016 Outlook; Q2 Revenue Increased 34% Year-over-Year

September 7, 2016

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today reported financial results for the second quarter ended June 30, 2016. Read the full press release here.


Tactile Systems Announces Closing of Initial Public Offering

August 2, 2016

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops innovative medical devices for the treatment of chronic diseases at home, announced the closing of its initial public offering on August 2nd, 2016, of 4,120,000 shares of common stock at a public offering price of $10.00 per share, before underwriting discounts and commissions. Read the full press release here.


Tactile Systems Announces Pricing of Initial Public Offering

July 27, 2016

Tactile Systems Technology, Inc. (“Tactile”) (Nasdaq:TCMD), a medical technology company that develops innovative medical devices for the treatment of chronic diseases at home, announced the pricing of its initial public offering July 27th, 2016, of 4,000,000 shares of common stock at a public offering price of $10.00 per share.. Read the full press release here.


Tactile Medical Named to Top Workplaces for Seventh Consecutive Year

June 27, 2016

For the seventh consecutive year, Tactile Medical was recognized as a Top Workplace by the Star Tribune. Employees from 1,556 companies were surveyed and Tactile Medical ranked 15 among midsize companies, a marked increase from its 2015 rank of 63 among small firms. Read the full press release here.


Groundbreaking Research Changes Outlook for Lymphedema Patients

October 7, 2015

Groundbreaking Research Changes Outlook for Lymphedema Patients; Pneumatic compression device shown to provide major clinical benefit, while lowering the overall cost of care. Read the full press release here.


March 28, 2014

Tactile Medical was awarded renewed accreditation by the Accreditation Commission for Health Care (ACHC) for compliance towards a comprehensive set of national standards for home health providers.


Net Health Announces Collaboration with Tactile Medical to Provide Pneumatic Compression Solutions

February 5, 2014

Tactile Medical offers customers the ability to order Flexitouch® and ACTitouch products electronically through Net Health’s WoundExpert software, the nation’s leading software solution for wound care.


October 30, 2013

During a recent FDA inspection Tactile Medical was not found to have any objectionable conditions or practices, a No Action Indication classification.


Star Tribune names Tactile Systems Technology, Inc. to Star Tribune’s Top Workplaces 2013

June 17, 2013

Tactile Medical named to Minneapolis Star Tribune Newspaper’s Top 100 Workplaces for 4th year in a row.


Tactile Systems Technology Announces Financing from Radius Ventures

October 4, 2012

Tactile Medical raises $10.4 million in Series B financing to acquire ACTitouch, a product that provides intermittent and continuous pressure for patients to manage chronic wounds.